Selective Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Selective Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-82	Closed	-$6K	–	334
2020 Q2	$6K	Hold	82	–	–	0.01%	279
2020 Q1	$5K	Hold	82	–	–	0.01%	199
2019 Q4	$4K	Hold	82	–	–	﹤0.01%	239
2019 Q3	$4K	Buy	+82	New	+$3.82K	0.01%	240

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Selective Wealth Management's EBS Position: Q3 2020 in Review

Selective Wealth Management sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 82 shares — an estimated $6K sold.

Selective Wealth Management first reported a position in EBS in Q3 2019 and held it in 4 quarters. The position peaked at $6K in Q2 2020. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

Selective Wealth Management reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
Selective Wealth Management sold 82 Emergent Biosolutions shares in Q3 2020, an estimated $6K.
Selective Wealth Management first reported a position in Emergent Biosolutions in Q3 2019 and held it in 4 quarters.
Selective Wealth Management's Emergent Biosolutions position peaked at $6K in Q2 2020.
358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Selective Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.